Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C

Archives of Ophthalmology

Volumn 117, Issue 4, 1999, Pages 544-545

  Haas, Keren ^b   Ben Dor, David ^b   Levartovsky, Shmuel ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

AGED; ARTICLE; CASE REPORT; CORNEA TUMOR; DNA SYNTHESIS INHIBITION; DRUG EFFICACY; EYE TUMOR; FEMALE; HUMAN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 0032943573     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.4.544     Document Type: Article

References (5)

1. Wilson MW, Hungerford JL, George SM, Madreperla SA. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997;124:303-311.
2. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:164-168.
3. Heigle TJ, Stulting R, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol. 1997;124:397-399.
4. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia. Ophthalmology. 1997;104:2085-2093.
5. Rubinfeld RS, Pfister RR, Stein RM,et al. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology. 1992;99:1647-1654.